Results 1 to 10 of about 11,301,269 (256)

Liver Regeneration and Cell Transplantation for End-Stage Liver Disease

Biomolecules, 2021
Liver transplantation is the only curative option for end-stage liver disease; however, the limitations of liver transplantation require further research into other alternatives.
Yan Li, Lungen Lu, Xiaobo Cai
doaj   +4 more sources

Invasive fungal disease in patients with end-stage liver disease. [PDF]

Infect Dis Immun
. Invasive fungal disease (IFD) has become a critical complication in patients with end-stage liver disease (ESLD), marked by a rising prevalence and the emergence of drug-resistant strains in recent decades.
Shou YR, Liu ZY.
europepmc   +2 more sources

Association of mild-to-moderate Model for End-Stage Liver Disease scores on short-term cardiac surgery postoperative outcomes. [PDF]

JTCVS Open
Objective: We assessed the Model for End-Stage Liver Disease score in patients with mild-moderate scores to predict perioperative outcomes in patients undergoing cardiac surgery.
Liu T, Chen Z, Jacobs RC, Logan CD, Whippo B, An S, McCarthy PM, Mehta CK.   +7 more
europepmc   +2 more sources

Evaluation of correlation between etiology of end stage liver disease and intraoperative utilization of blood products during liver transplantation. [PDF]

Saudi J Anaesth
Background: Liver transplantation is frequently associated with massive blood loss and utilization of blood products to optimize coagulation; this study aimed to evaluate their possible correlation with etiological and perioperative factors.
Majeed A, Jobeir BA, Shabbir M, Ibrahim M, Nagy MS, Tufail B, Raptis DA, Altukhaifi L, AlFattani AAG.   +8 more
europepmc   +2 more sources

Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease. [PDF]

BMC Gastroenterol
Background and aims Intestinal paralysis is a common complication in end-stage liver disease (ESLD), our aim is to assess the effectiveness and safety of low-dose terlipressin for treating intestinal paralysis in ESLD.
Wan X, Xu H, Li H, Zhong S, Lei Y, Deng H, Fu X, Zhou Z.   +7 more
europepmc   +2 more sources

Chronotropic incompetence in end-stage liver disease.

PLoS ONE, 2022
BackgroundCirrhosis causes alterations in the cardiovascular and autonomic nervous systems and leads to cirrhotic cardiomyopathy (CCM). CCM is defined as cardiac dysfunction characterized by an impaired systolic responsiveness to stress or exercise, and ...
Renata Główczyńska, Sonia Borodzicz-Jażdżyk, Michał Peller, Joanna Raszeja-Wyszomirska, Piotr Milkiewicz, Krzysztof Zieniewicz, Grzegorz Opolski   +6 more
doaj   +2 more sources

From Child-Pugh to MELD score and beyond: Taking a walk down memory lane

Annals of Hepatology, 2022
The Child-Turcotte-Pugh (CTP) and the MELD (Model for End-Stage Liver Disease) scores were designed to predict the outcome of decompressive therapy for portal hypertension.
Andres Ruf, Melisa Dirchwolf, Richard B. Freeman   +2 more
doaj   +1 more source

Opportunistic infections in end stage liver disease

Infectious Disease Reports, 2018
Liver cirrhosis is the 10th most common cause of death in Western world and infection is associated with a high morbidity and mortality, and represents the leading cause of acute liver decompensation.
Michele Bartoletti, Maddalena Giannella, Sara Tedeschi, Pierluigi Viale   +3 more
doaj   +1 more source

Palliative Care in Advanced Liver Disease: Similar or Different Palliative Care Needs in Patients with a Prospect of Transplantation? Prospective Study from a Portuguese University Hospital and Transplantation Center

GE: Portuguese Journal of Gastroenterology, 2023
Background and Aims: End-stage liver disease (ESLD) is an important cause of morbidity and mortality, comparable to a large extent to other organ insufficiencies. The need for palliative care (PC) in patients with ESLD is high.
Sara Neves Vieira da Silva, Patricia Baptista, Isabel Fonseca Silva, Elga Freire, Helena Pessegueiro Miranda   +4 more
doaj   +1 more source

The Model for End-Stage Liver Disease Score and the Follow-Up Period Can Cause the Shift of Circulating Lymphocyte Subsets in Liver Transplant Recipients

Frontiers in Medicine, 2022
Little is known about the shift of lymphocytes under the condition of the model for end-stage liver disease score and the follow-up period. Then, we detected the peripheral blood from liver transplant recipients by flow cytometry and compared the results.
Fei Pan, Shuang Cao, Xian-Liang Li, Ya-nan Jia, Ruo-lin Wang, Qiang He, Ji-Qiao Zhu   +6 more
doaj   +1 more source